Status:
COMPLETED
Effect of Bacillus Subtilis DE111® on Daily Bowel Movements
Lead Sponsor:
Deerland Enzymes
Collaborating Sponsors:
Kennesaw State University
Conditions:
Bowel Movement Regulation
Occasional Constipation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the efficacy of Bacillus subtilis DE111® probiotic for regulation of bowel movements.
Detailed Description
The purpose of this study is to determine the efficacy of the probiotic B. subtilis DE111® for regulation of bowel movements. A single capsule containing 1 x 10\^9 CFU B. subtilis is to be consumed on...
Eligibility Criteria
Inclusion
- Participants suffering from occasional constipation and/or diarrhea will be eligible for participation.
Exclusion
- Blood CRP levels for each participant will be monitored at days 0, 60 and 105 of this study. Participants with CRP levels greater than 5mg/l on day 0 of the study will be excluded from further participation as this level is indicative of underlying inflammatory bowel disease. Participants excluded under such conditions will be instructed to seek further treatment with their health care provider.
Key Trial Info
Start Date :
September 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04083521
Start Date
September 1 2016
End Date
August 31 2017
Last Update
September 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kennesaw State University
Kennesaw, Georgia, United States, 30144